The company has reported sales of $15 billion for the first quarter of 2009, a decrease of 7.2%, compared to $16.19 billion for the first quarter of 2008.
William Weldon, chairman and CEO of Johnson & Johnson, said: “Despite challenging economic and near-term business pressures, we continue to deliver solid financial results. We are continuing to make strategic investments in order to bring important new products to market, positioning us well for long-term growth.”